| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | +11.19% | +3.97% | +11.37% | +19.43% | +15.93% | +17.74% | +13.47% | — | — | +13.30% |
| NIFTY Pharma TRI | +10.85% | +7.49% | +14.67% | +25.66% | +25.86% | +22.31% | +16.87% | — | — | — |
| Category middle | +6.85% | +0.56% | +8.14% | +3.99% | +3.08% | +13.26% | +11.84% | +16.64% | +14.59% | — |
| Volatility | 15.88% |
| Sharpe | 0.71 |
| Sortino | 1.09 |
| Beta | 0.98 |
| Alpha | -3.37% |
| Deepest fall | -18.53% |
| 1-year periods with a loss | 26% |
| 5Y SIP XIRR | — |
The fund house's monthly portfolio filing is not loaded.
Calculated by Growth Analyser from AMFI NAVs. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.